This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at email@example.com or call 800-767-3771 ext. 9339.
•Reports say another federal probe into Goldman Sachs' (NYSE:GS) handling of CDO is in the works, regarding a $2 billion Hudson Mezzanine offering sold in 2006
•Old Republic (NYSE:ORI) announced plans to merge with PMA Capital (NASDAQ:PMACA), in a $365 million deal
•Citigroup (NYSE:C) upgraded shares of Martin Marietta Materials (NYSE:MLM) to “hold from "sell"
•Keybanc upgraded Crane (NYSE:CR) to "buy" from "hold," with a $39 price target
•Lululemon (NASDAQ:LULU) reported better-than-projected first quarter earnings of 27 cents a share, ahead of Zacks estimates of 21 cents, on revenues of $138.3 million, which topped Zacks estimates of $129 million
•Auriga upgraded Omnicell (NASDAQ:OMCL) to "buy" from "hold," with a $15 price target
•Human Genome Sciences (NASDAQ:HGSI) said it is seeking FDA approval of experimental lupus drug Benlysta, being co-developed with GlaxoSmithKline (NYSE:GSK)
•Keybanc reiterated its buy rating on Tenneco (NYSE:TEN) with a $36 price target and maintained its buy on FMC (NYSE:FMC) with a $71 price target
Please login to Zacks.com or register to post a comment.